Table 2 Univariate and multivariate analysis results in Training cohort(n = 116)
From: Nomogram predict relapse-free survival of patients with thymic epithelial tumors after surgery
Variable | Univariate analysis | Multivariate analysis | Â | Â |
|---|---|---|---|---|
| Â | P | HR | 95%CI | P |
Gender Male vs Female | .545 | Â | Â | Â |
Age (years) ≤60 vs >60 | .175 |  |  |  |
Smoking history Never vs Ever | .516 | Â | Â | Â |
Drinking history No vs Yes | .128 | Â | Â | Â |
Family history of tumor No vs Yes | .858 | Â | Â | Â |
Underlying diseases No vs Yes | .176 | Â | Â | Â |
Tumor size ≤6 vs >6 | .225 |  |  |  |
pT stage | .020 | Reference | Â | Â |
T1 vs T2–3 |  | 7.518 | 1.355–41.718 | .021 |
Masaoka stage I vs II-III | .097 | Â | Â | Â |
WHO stage | .015 | Reference | Â | .016 |
A-AB vs B1-B3 |  | .379 | .070–2.040 | |
A-AB vs C |  | 5.892 | .660–52.582 | |
Myasthenia gravis, No vs Yes | .434 | Â | Â | Â |
tumor capsule status Incomplete vs Complete | .000 | Â | Â | .088 |
Invasion of great vessels No vs Yes | .000 | Â | Â | .117 |
ALB | .001 | Reference | Â | Â |
≤40.8 vs >40.8 |  | .157 | .035–.697 | .015 |
GLB ≤28.8 vs >28.8 | .446 |  |  |  |
A/G ≤1.5 vs >1.5 | .344 |  |  |  |
NE ≤5.6 vs >5.6 | .004 |  |  | .261 |
LY ≤2.5 vs >2.5 | .305 |  |  |  |
NE/LY (NLR) | .000 | Reference | Â | Â |
≤3.0 vs >3.0 |  | 15.426 | 1.759–135.300 | .014 |
PLT ≤237 vs >237 | .075 |  |  |  |
PLT/LY (PLR) ≤161.6 vs >161.6 | .041 |  |  | .082 |
PLT/NE*LY (SII) ≤764.3 vs >764.3 | .010 |  |  | .196 |